lobbying_filings_raw: 69964ea4-cf0a-4f22-ae35-6dc3d7f02f90

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
69964ea4-cf0a-4f22-ae35-6dc3d7f02f90 Q1 400703107 THE GIBSON GROUP, LLC 194417 ASSOCIATION FOR ACCESSIBLE MEDICINES 2026 first_quarter 2026-04-09T14:10:03-04:00 60000.0 0 0 0 {"url": "https://lda.gov/api/v1/filings/69964ea4-cf0a-4f22-ae35-6dc3d7f02f90/", "filing_uuid": "69964ea4-cf0a-4f22-ae35-6dc3d7f02f90", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2026, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.gov/filings/public/filing/69964ea4-cf0a-4f22-ae35-6dc3d7f02f90/print/", "filing_document_content_type": "text/html", "income": "60000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Joseph H. Gibson", "dt_posted": "2026-04-09T14:10:03-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "601 Thirteenth Street, N.W.", "registrant_address_2": "Suite B2 North", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 400703107, "url": "https://lda.gov/api/v1/registrants/400703107/", "house_registrant_id": 41536, "name": "THE GIBSON GROUP, LLC", "description": "â\u20ac\u2039Government Affairs Consulting Firm.", "address_1": "601 Thirteenth Street, N.W.", "address_2": "Suite B2 North", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JOSEPH GIBSON", "contact_telephone": "+1 202-744-2827", "dt_updated": "2026-02-26T10:08:05.696799-05:00"}, "client": {"id": 194417, "url": "https://lda.gov/api/v1/clients/194417/", "client_id": 140, "name": "ASSOCIATION FOR ACCESSIBLE MEDICINES", "general_description": "National trade organization representing the interests of generic drug manufacturers.", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2016-09-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Drug competition issues Monitor drug supply chain issues", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54211, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "H", "last_name": "GIBSON", "suffix": null, "suffix_display": null}, "covered_position": "Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "LBR", "general_issue_code_display": "Labor Issues/Antitrust/Workplace", "description": "Drug competition issues", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54211, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "H", "last_name": "GIBSON", "suffix": null, "suffix_display": null}, "covered_position": "Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54211, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "H", "last_name": "GIBSON", "suffix": null, "suffix_display": null}, "covered_position": "Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "Monitor issues related to trade agreeements", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54211, "prefix": "mr", "prefix_display": "MR.", "first_name": "JOSEPH", "nickname": null, "middle_name": "H", "last_name": "GIBSON", "suffix": null, "suffix_display": null}, "covered_position": "Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997", "new": false}], "government_entities": []}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 41536 DC DC US US National trade organization representing the interests of generic drug manufacturers. 0 0 987797   normalized_name_state 0.9

Links from other tables